Current updates on the structural and functional aspects of the CRISPR/Cas13 system for RNA targeting and editing: A next‑generation tool for cancer management (Review).

Int J Oncol · 2025 · PMC12068846 · PMID 40342053

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Optimizing the delivery of CRISPR/Cas13 to cancer cells is challenging but highly significant for enhancing its therapeutic efficacy.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.